Biopharma R&D Business Development Platform - Biopharma R&D Business Development Platform
Location: United States, New York, Syracuse
Total raised: $500K
Funding Rounds 1
Date | Series | Amount | Investors |
16.02.2024 | Seed | $500K | - |
Mentions in press and media 6
Date | Title | Description |
16.02.2024 | BioNeex Raises $500K in Seed Funding | BioNeex, a NYC-based provider of a biopharmaceutical industry’s research and development (R&D) business development platform, raised $500K in Seed funding. The round was led by biopharma industry leaders, including former executives at ... |
16.02.2024 | BioNeex Raises $500K Seed Round | NEW YORK, NY, BioNeex, a biopharmaceutical research and development business development platform, has successfully closed its $0.5 million seed round of financing. >> Click here for more funding data on BioNeex >> To export... |
30.01.2023 | BioNeex and TVM Capital Life Science Launch Global Forum Bringing Together Biotech Companies and Venture Capital Firms | New York, NY (PRWEB) January 30, 2023 BioNeex (http://www.bioneex.com), the biopharma industry’s first research and development (R&D) open exchange platform for drug candidates licensing, co-development partnerships, and investments, an... |
11.10.2022 | Former Pfizer Executive Dr. Andreas Penk Joins BioNeex Advisory Board | NEW YORK (PRWEB) October 11, 2022 BioNeex (http://www.bioneex.com), the biopharma industry’s first research and development (R&D) open exchange platform, announced today former Pfizer executive Dr. Andreas Penk has joined its Advisory B... |
22.03.2022 | BioNeex and ALSA Ventures Partner to Provide Biotech Firms a New Way to Drug Candidate Out-Licensing and Acquiring Investment | NEW YORK (PRWEB) March 22, 2022 BioNeex (http://www.bioneex.com), the biopharma industry’s first research and development (R&D) open exchange platform, announced today it is partnering with ALSA Ventures to help preclinical and early cl... |
- | BioNeex | “Biopharma R&D Business Development Platform - Biopharma R&D Business Development Platform” |